Journal of Materials Chemistry B,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 4, 2024
The
aim
of
this
review
is
to
elucidate
the
pathomechanism
MIRI
and
present
latest
developments
in
use
TCM
monomers
nanomaterials
combination
with
for
treatment
MIRI.
Vascular Pharmacology,
Год журнала:
2023,
Номер
152, С. 107208 - 107208
Опубликована: Авг. 11, 2023
Here
we
aimed
to
establish
an
in
vitro
engineered
heart
tissue
(EHT)
co-morbidity
mimicking
model
of
ischemia-reperfusion
injury
and
diabetes.
EHTs
were
generated
from
primary
neonatal
rat
cardiomyocytes.
Hyperglycemic
conditions
or
hyperosmolar
controls
applied
for
one
day
acute
hyperglycemia
seven
days
chronic
hyperglycemia.
120
min'
simulated
ischemia
(SI)
was
followed
by
reperfusion
(R)
1-day
follow-up
(FR).
Normoxic
(N)
not
subjected
SI/R.
Half
the
paced,
other
half
left
unpaced.
To
assess
cell
injury,
lactate-dehydrogenase
(LDH)
concentration
measured.
Beating
force
activity
(frequency)
monitored
as
cardiomyocyte
functional
parameters.
LDH-release
indicated
relevant
after
SI/N
each
experimental
condition,
with
much
higher
effects
chronically
hyperglycemic/hyperosmolar
groups.
SI
stopped
beating
which
returned
during
reperfusion,
weaker
recovery
than
conditions.
Acutely
treated
showed
small
∼80%
follow-up,
while
a
marked
LDH-release,
only
∼30%
complete
loss
24
h
reperfusion.
We
conclude
that
respond
differently
SI/R
hyperglycemia/hyperosmolarity,
our
EHT
is
novel
combination
diabetes
ischemia-reperfusion.
Cardiology Research and Practice,
Год журнала:
2024,
Номер
2024(1)
Опубликована: Янв. 1, 2024
Myocardial
ischemia‐reperfusion
(I/R)
injury
is
a
significant
area
of
focus
in
cardiovascular
disease
research.
I/R
can
increase
intracellular
oxidative
stress,
leading
to
DNA
damage.
H2AX
plays
crucial
role
repair.
This
study
utilized
mouse
and
cell
models
myocardial
investigate
the
impact
on
cardiomyocytes
during
I/R.
initially
assessed
expression
MI/R
mice
compared
sham
surgery
group.
Subsequently,
cardiac
function,
infarct
area,
mitochondrial
damage
were
evaluated
after
inhibiting
negative
control
Furthermore,
delved
into
molecular
mechanisms
by
analyzing
H2AX,
P53,
p‐JNK,
SHP2,
p‐SHP2,
p‐RAS,
parkin,
Drp1,
Cyt‐C,
Caspase‐3,
Caspase‐8
following
addition
JNK
or
P53
agonists.
The
results
from
western
blotting
vivo
indicated
significantly
higher
group
Inhibiting
improved
reduced
mitigated
In
vitro
experiments
demonstrated
that
could
attenuate
apoptosis
cells
modulating
signaling
pathways.
These
findings
suggested
may
alleviate
through
regulation
P53/JNK
pathway,
highlighting
as
potential
target
for
treatment
ischemia/reperfusion
injury.
Lin28A
is
an
oncoprotein
overexpressed
in
several
cancer
types
such
as
testicular,
ovarian,
colon,
breast
and
lung
cancers.
As
a
pluripotency
factor
that
promotes
tumorigenesis,
associated
with
more
undifferentiated
aggressive
tumors
phenotypes.
Moreover,
highly
stable
protein
difficult
to
downregulate.
The
compound
resveratrol
(RSV)
has
anticancer
effects.
present
study
aimed
elucidate
the
mechanisms
underlying
downregulation
of
expression
by
RSV
NCCIT
cell
line.
cells
were
treated
different
concentrations
investigate
its
effects
on
expression.
mRNA
levels
ubiquitin-specific
protease
28
(USP28)
assessed
using
reverse
transcription-quantitative
PCR.
Western
blot
analysis
was
employed
evaluate
Lin28A,
USP28
phosphorylated
Lin28A.
In
addition,
some
experiments,
MAPK/ERK
pathway
inhibitor,
other
experiments
involved
transfecting
small
interfering
RNAs
targeting
USP28.
results
demonstrated
significantly
reduced
destabilizing
protein;
this
effect
mediated
ability
suppress
USP28,
deubiquitinase
normally
protects
from
ubiquitination
degradation.
Additionally,
inhibited
phosphorylation
via
pathway;
event
previously
been
shown
enhance
stability
increasing
half-life.
This
resulted
degradation
through
proteasomal
cells.
provide
further
evidence
activity
RSV,
identified
promising
therapeutic
targets.
oncoprotein,
downregulating
challenging.
However,
can
overcome
hurdle
inhibiting
signaling
promote
Furthermore,
elucidating
these
provides
avenues
for
developing
targeted
therapies.
Journal of Materials Chemistry B,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 4, 2024
The
aim
of
this
review
is
to
elucidate
the
pathomechanism
MIRI
and
present
latest
developments
in
use
TCM
monomers
nanomaterials
combination
with
for
treatment
MIRI.